Polish researchers, together with scientists from Norway, Sweden and the Netherlands, assessed the impact of screening colonoscopy on the reduction of incidence and death from colorectal cancer. The New England Journal of Medicine published the results of the NORDICC study conducted in 4 countries, in which researchers from the National Institute of Oncology Maria Skłodowskiej Curie and the Medical Center of Postgraduate Education in Warsaw under the supervision of prof. Michał Kamiński.
It is the world's first randomized trial to assess the impact of screening colonoscopy on the risk of developing and dying from colorectal cancer. The scientific evidence to date assessing the magnitude of the reduction in the risk of developing and dying from colorectal cancer after colonoscopy has been obtained in observational studies.
The NORDICC (Northern European Initiative on Colorectal Cancer) study was conducted in 4 countries: Norway, Sweden, the Netherlands and Poland. A...
Content locked
To gain access to the complete English section of the Medexpress.pl, kindly reach out to us at [email protected].
If you already have an account, please log in
